Author:
Kianmehr Anvarsadat,Golavar Raziyeh,Rouintan Mandana,Mahrooz Abdolkarim,Fard-Esfahani Pezhman,Oladnabi Morteza,Khajeniazi Safoura,Mostafavi Seyede Samaneh,Omidinia Eskandar
Funder
Pasteur Institute of Iran
Reference24 articles.
1. Darbepoetin alfa has a longer circulating half-life and great in vivo potency than recombinant human erythropoietin;Egrie;Expl. Hematol.,2003
2. Development and characterization of novel erythropoiesis stimulating protein (NESP);Egrie;Nephrol. Dial. Transpl.,2001
3. Pharmacokinteics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients;Macdougall;Clin. J. Am. Soc. Nephrol.,1999
4. Novel erythropoiesis-stimulating agents: a new era in anemia management;Macdougall;Clin. J. Am. Soc. Nephrol.,2008
5. Rational design of novel erythropoiesis stimulating protein (ARANESP): a super-sialated molecule with increased biological activity;Elliott;Blood,2000
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献